North America artificial tear market was valued at $638.8 million in 2025 and is projected to reach $1,021.7 million by 2035, growing at a CAGR of 4.9% during the forecast period (2026–2035). The market expansion is driven by the rising prevalence of dry eye syndrome, increasing screen time and digital device usage, aging populations, and growing awareness of ocular health. Artificial tear products, including lubricating eye drops, gels, ointments, and preservative-free formulations, are increasingly preferred for managing dry eye symptoms and improving patient quality of life. Key trends shaping the market include the development of preservative-free and multi-dose formulations, integration of advanced hydrating polymers and natural extracts, and increasing adoption of over-the-counter (OTC) products for self-managed eye care. Regional growth is supported by rising healthcare access, greater ophthalmology awareness, and targeted marketing initiatives by key manufacturers.
Browse the full report description of “North American Artificial Tears Market Size, Share & Trends Analysis Report by Type (Cellulose-Derived Tears, Glycerin-Derived Tears, Oil-Based Emulsion Tears, and Polyethylene Glycol- & Propylene Glycol-Based Tears), By Delivery Method (Eyedrops and Ointments/Gel), By Application (Dry Type Treatment, Contact Lens Moisture, and Digital Eye Strain) and By End-User (Retail Pharmacies (OTC), Online Pharmacies, Hospitals & Ophthalmic Clinics, and Other End User) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/north-american-artificial-tears-market
According to PMC, Sjögren’s Canada, and the National Eye Institute (NEI), the prevalence of dry eye disease (DED) and related ocular symptoms in North America is substantial, driving increased demand for artificial tears across clinics, pharmacies, and consumer channels, especially as aging, screen time, and environmental factors contribute to eye surface irritation.
Key Innovators Driving North America Artificial Tear Transformation
The key players in the North America artificial tear market include AbbVie Inc., Alcon Inc., Bausch Health Companies Inc., Rohto Pharmaceutical Co., Ltd., Santen Pharmaceutical Co., Ltd., among others. These companies are driving innovation through new formulations, enhanced delivery systems, and global distribution strategies.
Market Coverage
Key questions addressed by the report.
North America Artificial Tear Market Report Segment
By Type
By Delivery Method
By Application
By End-User
North America Artificial Tear Market Report Segment by Country
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-artificial-tears-market